TruNorth Capital Management’s AbbVie ABBV Stock Holding History

TruNorth Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$483K	Buy	1,921 +127	+7%	+$27.3K	0.08%	69
2026 Q1	$390K	Buy	1,794 +6	+0.3%	+$1.33K	0.07%	68
2025 Q4	$409K	Buy	1,788 +60	+3%	+$13.7K	0.08%	69
2025 Q3	$400K	Buy	1,728 +342	+25%	+$69.6K	0.08%	68
2025 Q2	$257K	Sell	1,386 -1,552	-53%	-$288K	0.06%	76
2025 Q1	$616K	Buy	2,938 +1,552	+112%	+$302K	0.15%	51
2024 Q4	$246K	Hold	1,386	–	–	0.07%	63
2024 Q3	$274K	Hold	1,386	–	–	0.08%	55
2024 Q2	$238K	Hold	1,386	–	–	0.08%	59
2024 Q1	$252K	Buy	+1,386	New	+$239K	0.09%	53

Other funds holding ABBV

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

TruNorth Capital Management's ABBV Position: Q2 2026 in Review

TruNorth Capital Management increased its AbbVie (ABBV) stake by 7.1% in Q2 2026, buying an estimated $27.3K and bringing the position to 1,921 shares worth $483K. The position accounts for 0.08% of the portfolio, ranked #69.

TruNorth Capital Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $616K in Q1 2025. 2,161 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

TruNorth Capital Management held 1,921 shares of AbbVie worth $483K as of Q2 2026.
TruNorth Capital Management bought 127 AbbVie shares in Q2 2026, an estimated $27.3K.
AbbVie made up 0.08% of TruNorth Capital Management's portfolio in Q2 2026, its #69 holding.
TruNorth Capital Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
TruNorth Capital Management's AbbVie position peaked at $616K in Q1 2025.
2,161 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TruNorth Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.